PLP1 alternative splicing in differentiating oligodendrocytes: Characterization of an exonic splicing enhancer

Proteolipid protein (PLP) and DM20 are generated by alternative splicing of exon 3B of PLP1 transcript in differentiating oligodendrocytes. We investigated the role of exonic splicing enhancers (ESE) in the selection of PLP 5′ donor site, focusing on putative ASF/SF2, and SC35 binding motifs in exon 3B on the basis of mutations that cause disease in humans. Mutations in a putative ASF/SF2 binding motif (nucleotides 406–412) reduced PLP 5′ donor site selection, whereas a mutation in a putative SC35 binding motif (nucleotides 382–389) had no effect. UV crosslinking and immunoprecipitation (IP) assays using an antibody to ASF/SF2 showed that the ASF/SF2 protein specifically binds to the ESE (nucleotides 406–412). The single nucleotide mutations that reduced PLP splice site selection greatly diminished ASF/SF2 protein binding to this motif. We next tested the effect of overexpressed ASF/SF2 on PLP 5′splice selection in differentiating oligodendrocytes. ASF/SF2 positively regulates PLP splice site selection in a concentration‐dependent manner. Disruption of the putative ASF/SF2 binding site in exon 3B reduced the positive effect of ASF/SF2 on PLP splicing. We conclude that an ESE in exon3B regulates PLP 5′ donor site selection and that ASF/SF2 protein participates in the regulation of PLP alternative splicing in oligodendrocytes. J. Cell. Biochem. 97: 999–1016, 2006. © 2005 Wiley‐Liss, Inc.

[1]  Xiang-Dong Fu,et al.  ASF/SF2-Regulated CaMKIIδ Alternative Splicing Temporally Reprograms Excitation-Contraction Coupling in Cardiac Muscle , 2005, Cell.

[2]  S. Stamm,et al.  Function of Alternative Splicing , 2004 .

[3]  S. Stamm,et al.  Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors , 2004, Journal of neurochemistry.

[4]  E. Buratti,et al.  Exon Enhancer Elements in the Fibronectin EDA Proteins by Mouse and Human Polypurinic RNA Folding Affects the Recruitment of SR , 2004 .

[5]  David L. Spector,et al.  Nuclear speckles: a model for nuclear organelles , 2003, Nature Reviews Molecular Cell Biology.

[6]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[7]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[8]  Peter K Rogan,et al.  Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations. , 2003, Pharmacogenetics.

[9]  E. Bertini,et al.  Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy , 2003, Annals of neurology.

[10]  S. Sugano,et al.  A vertebrate RNA‐binding protein Fox‐1 regulates tissue‐specific splicing via the pentanucleotide GCAUG , 2003, The EMBO journal.

[11]  Wei Jiang,et al.  The Unfolded Protein Response Modulates Disease Severity in Pelizaeus-Merzbacher Disease , 2002, Neuron.

[12]  H. Marks,et al.  A PLP splicing abnormality is associated with an unusual presentation of PMD , 2002, Annals of neurology.

[13]  A. Krainer,et al.  Nuclear Export and Retention Signals in the RS Domain of SR Proteins , 2002, Molecular and Cellular Biology.

[14]  Stefan Stamm,et al.  Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. , 2002, Human molecular genetics.

[15]  W. Macklin,et al.  Myelin Proteolipid Protein Forms a Complex with Integrins and May Participate in Integrin Receptor Signaling in Oligodendrocytes , 2002, The Journal of Neuroscience.

[16]  Jack A. Taylor,et al.  Splice variants but not mutations of DNA polymerase beta are common in bladder cancer. , 2002, Cancer research.

[17]  A. Krainer,et al.  Alternative Splicing of the Adenylyl Cyclase Stimulatory G-protein Gαs Is Regulated by SF2/ASF and Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNPA1) and Involves the Use of an Unusual TG 3′-Splice Site* , 2002, The Journal of Biological Chemistry.

[18]  A. Kornblihtt,et al.  Alternative splicing: multiple control mechanisms and involvement in human disease. , 2002, Trends in genetics : TIG.

[19]  A. Krainer,et al.  Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 , 2002, Nature Genetics.

[20]  Erik A Sistermans,et al.  Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. , 2002, Brain : a journal of neurology.

[21]  F. Cambi,et al.  Down-Regulation of the Retinoblastoma Protein (Rb) Is Associated with Rat Oligodendrocyte Differentiation , 2002, Molecular and Cellular Neuroscience.

[22]  W. Stoffel,et al.  Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: Myelination and development , 2002, Glia.

[23]  A. Krainer,et al.  Pre-mRNA splicing in the new millennium. , 2001, Current opinion in cell biology.

[24]  Susan M. Berget,et al.  An Intronic Splicing Enhancer Binds U1 snRNPs To Enhance Splicing and Select 5′ Splice Sites , 2000, Molecular and Cellular Biology.

[25]  V. Friedrich,et al.  The Evolution of Lipophilin Genes from Invertebrates to Tetrapods: DM-20 Cannot Replace Proteolipid Protein in CNS Myelin , 2000, Journal of Neuroscience.

[26]  B. Blencowe.  Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. , 2000, Trends in biochemical sciences.

[27]  A. Krainer,et al.  Identification of Functional Exonic Splicing Enhancer Motifs Recognized by Individual Sr Proteins Using an in Vitro Randomization and Functional Selection Procedure, We Have Identified Three Novel Classes of Exonic Splicing Enhancers (eses) Recognized by Human Sf2/asf, Srp40, and Srp55, Respectively , 2022 .

[28]  R. Lazzarini,et al.  Disrupted Proteolipid Protein Trafficking Results in Oligodendrocyte Apoptosis in an Animal Model of Pelizaeus-Merzbacher Disease , 1998, The Journal of cell biology.

[29]  S. Berget,et al.  G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection , 1997, Molecular and cellular biology.

[30]  A. Krainer,et al.  Role of the Modular Domains of SR Proteins in Subnuclear Localization and Alternative Splicing Specificity , 1997, The Journal of cell biology.

[31]  T. Pawson,et al.  SRPK1 and Clk/Sty Protein Kinases Show Distinct Substrate Specificities for Serine/Arginine-rich Splicing Factors* , 1996, The Journal of Biological Chemistry.

[32]  A. Aguzzi,et al.  Lines of Murine Oligodendroglial Precursor Cells Immortalized by an Activated neu Tyrosine Kinase Show Distinct Degrees of Interaction with Axons In Vitro and In Vivo , 1995, The European journal of neuroscience.

[33]  J. Gui,et al.  Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Michael Ruogu Zhang,et al.  A sequence compilation and comparison of exons that are alternatively spliced in neurons. , 1994, Nucleic acids research.

[35]  A. Zahler,et al.  Human SR proteins and isolation of a cDNA encoding SRp75 , 1993, Molecular and cellular biology.

[36]  C. Will,et al.  Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors. , 1993, Nucleic acids research.

[37]  A. Krainer,et al.  General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Staugaitis,et al.  The DM20 Protein of Myelin: Intracellular and Surface Expression Patterns in Transfectants , 1992, Journal of neurochemistry.

[39]  J. Manley,et al.  A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro , 1990, Cell.

[40]  F. Bloom,et al.  Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Schachner,et al.  Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. , 1981, Developmental biology.

[42]  M. Nirenberg,et al.  Monoclonal antibody to a plasma membrane antigen of neurons. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[43]  F. Cambi,et al.  Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes , 1998, Journal of cellular biochemistry.

[44]  A. Krainer,et al.  A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. , 1998, Genes & development.

[45]  W. Macklin,et al.  Developmental expression of proteolipid protein and DM20 mRNAs and proteins in the rat brain. , 1990, Developmental neuroscience.